Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-043005·Five Narrow Lane LP
Schedule 13G ownership disclosure
GT BIOPHARMA INC
COMMON STOCK, $0.001 PAR VALUE PER SHARE · CUSIP: 36254L308
Event date: 2025-05-13
- Filing-level shares
- 253,388.00
- Percent of class
- 9.99%
- Five Narrow Lane LP
Shares: 253,388.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-043005
- Form type
- SCHEDULE 13G
- Filer
- Five Narrow Lane LP
- CIK
- CIK 1927401
- Filed
- May 14, 2025
- Reporting period
- May 13, 2025
- Description
- Schedule 13G beneficial ownership